Flex Biomedical gets $866,000 from investors
Flex Biomedical, a Madison company developing treatments for orthopedic diseases, has received $866,000 from investors, the Wisconsin State Journal reports. The money will be used to advance the Flex Polymer, a synthetic polymer designed to treat osteoarthritis. (WISCONSIN STATE JOURNAL, 1/28)
To access this content, you must purchase a Premium membership, or log in if you are a member.
